Orthopedic Digit Implants Market Size, Share, and Indsutry Analysis, By Product Type (Hand {Metacarpal Joint Implants, Scaphoid Bone Implants, and Others}, and Foot {Metatarsal Joint Implants, Hemi Phalangeal Implants, and Others}), By Material (Titanium, Nitinol, Silicon Pyrocarbon, Stainless Steel, and Others), By Application (Rheumatoid Arthritis, Trauma/Fractures, Deformities, and Others), By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

The global orthopedic digit implants market size was valued at USD 304.36 million in 2025. The market is projected to grow from USD 326.82 million in 2026 to USD 577.69 million by 2034, exhibiting a CAGR of 7.38% during the forecast period.

The orthopedic digit implants market is witnessing significant growth due to the increasing volume of finger and toe joint implantation procedures, driven by the increased incidence of sports injuries requiring intervention. Moreover, the high burden of joint deformities in the hand and foot due to rheumatoid arthritis is also expected to boost the demand for finger and toe joint implantation, driving the market growth during the forecast period.

• For instance, according to the study published by the Annals of the Rheumatic Diseases in June 2025, nearly a quarter of rheumatoid arthritis patients have hand joint deformities out of the 1,083 recruited patients.

Orthopedic Digit Implants Market Driver

Rising Incidence of Chronic Diseases and Traumatic Injuries to Fuel Market Growth

Over the past few years, there has been a significant rise in the incidence of osteoarthritis and traumatic injuries involving fingers and toes. Moreover, the increasing geriatric population is contributing significantly to the rise in incidence of osteoarthritis and rheumatoid arthritis. Moreover, the traumatic injuries are also growing due to sports and work-related accidents, which are increasing the demand for surgical intervention in small joints. In such conditions, patients are seeking improved mobility and pain relief, fueling the adoption of advanced implantable solutions, including pyrocarbon and silicone-based digit implants. This demand is further expected to increase due to high awareness of digit reconstruction procedures and higher surgical success rates, driving the market growth in the coming years.

• For instance, as of July 2025, the Arthritis Foundation mentioned that osteoarthritis has affected over 32.5 million adults in the U.S.

Global Burden of Rheumatoid Arthritis, By Year 2020 and 2050

According to The Lancet Rheumatology in October 2023, the prevalence of rheumatoid arthritis is expected to rise to 31.7 million by 2050. 

Orthopedic Digit Implants Market Restraint

High Implant Cost to Hinder Market Growth

Orthopedic digit implants, especially those made with advanced materials such as pyrocarbon, are expensive, limiting accessibility in low- and middle-income settings. Additionally, these surgeries are often categorized as elective in certain healthcare systems, resulting in out-of-pocket expenses for patients. As a result, the limited standardized reimbursement policies and limited coverage from private insurers are expected to pose a barrier to market growth, particularly in emerging and low-income countries, hampering market growth.

• For instance, according to the data published by the Journal of Orthopedic Experience & Innovation in October 2024, pyrocarbon implants are comparatively more expensive.

Orthopedic Digit Implants Market Opportunity

Emergence of Next-Generation Biomaterials and 3D Printing Technologies to Offer Lucrative Growth Opportunity

In recent years, advanced materials such as biocompatible polymers, pyrocarbon, and titanium alloys have been enhancing implant longevity and reducing post-operative complications, driving the demand for implantation procedures. Furthermore, the integration of 3D printing is enabling the fabrication of customized implants tailored to individual anatomical needs, improving surgical outcomes and patient satisfaction. This personalization is especially valuable in trauma cases or congenital deformities requiring a unique implant structure. As a result, companies are increasingly investing in R&D for cost-effective, patient-specific digit implants, offering a lucrative opportunity for market growth.

• For instance, according to the data published by the National Center for Biotechnology Information (NCBI), 3D printing technology has enabled the precise fabrication of complex metal implants according to the anatomy of the bone. 

Key Insights

The report covers the following key insights:

• Estimated Number of Key Procedures, By Key Countries/Region, 2024
• Prevalence of Key Diseases, By Key Countries/Region, 2024
• Key Industry Developments – (Mergers, Acquisitions & Partnerships, etc.)
• New Product Launch/Approvals, By Key Players
• Regulatory & Reimbursement Scenario

Segmentation

Analysis by Product Type

By product type, the market is divided into (hand {metacarpal joint implants, scaphoid bone implants, and others}, and foot {metatarsal joint implants, hemi phalangeal implants, and others}.

The hand segment is expected to account for the largest market share during the forecast period. The growth is attributed to increasing hand joint reconstruction procedures to correct the deformities caused by fractures, lupus, bone cancer, and osteomyelitis. As a result, the increasing burden of such conditions is expected to spur the demand for orthopedic digit implantation procedures. Moreover, the advancements in the procedures and techniques are favoring the demand for such procedures due to significant benefits such as less blood loss, shortened recovery period, and others. 

• For instance, according to the data published by the American Cancer Society, Inc., around 3,770 new bone cancer cases were diagnosed in 2025. 

Analysis by Material

By material, the market is divided into titanium, nitinol, silicon pyrocarbon, stainless steel, and others.

The titanium segment is expected to hold a major share during the projection period. The growth is attributed to a high preference for titanium implants due to their superior biocompatibility and strength. These properties are offering durability, increasing the adoption rate among healthcare providers and patients. In consideration, key players are focusing on launching titanium-based metatarsal, metacarpal, and other joint implants to increase their market availability and cater to the demand for rising finger and toe arthroplasty.

• For instance, according to the article published by Dr. Oracle in May 2025, titanium (Ti) links in orthopedic implants are increasingly preferred due to their excellent mechanical strength, biocompatibility, and corrosion resistance.

Analysis by Application

By application, the market is divided into rheumatoid arthritis, trauma/fractures, deformities, and others.

The trauma/fractures segment is expected to hold a major share during the projection period. The growth is attributed to the increasing number of trauma & fracture cases globally due to road accidents and sports injuries. These conditions are driving the need for arthroplasty procedures for the hand and foot, including the small joints such as toes and fingers, favoring the utilization of orthopedic digit implants. 

• For instance, according to the study published by the NCBI in February 2021, the overall incidence of foot fractures was 142.3 per 100,000 individuals each year in Europe.

Analysis by End-user

By end-user, the market is divided into hospitals & ASCs, specialty clinics, and others.

The hospital & ASCs segment is expected to hold the highest market share in the forthcoming years. The growth is attributed to the high preference of patients to undergo arthroplasty procedures in hospital settings due to greater supervision of experts and the availability of advanced technologies for joint replacement surgeries. In addition, the increasing number of ASCs to cater to the rising demand for such surgeries is also anticipated to fuel the market expansion.

• For instance, as per the data provided by the Centers for Medicare & Medicaid Services (CMS) in March 2025, there were more than 6,300 Medicare-certified ASCs in the U.S.

Regional Analysis

By region, the market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.

Request for Customization   to gain extensive market insights.

North America held the largest global orthopedic digit implants market share in 2024. The growth is attributed to the region’s established healthcare infrastructure, thereby favoring the adoption of reconstructive surgeries. Moreover, the favorable reimbursement policies in the U.S., along with the presence of prominent players, are also catering to the high demand for joint replacement procedures, including small joints.

• For instance, as of July 2025, the repair, revision, and/or reconstruction procedures on the hand and fingers are covered under CPT 26535 by Medicare.

Asia Pacific is expected to grow at the highest CAGR in the forthcoming years. The growth is driven by a large patient pool and growing awareness of hand and foot surgeries, propelling the utilization of orthopedic digit implants. Moreover, the expanding access to healthcare in countries such as China and India is driving the adoption of minimally invasive surgical technologies, which are expected to accelerate market expansion during the forecast period.

Key Players Covered

The global orthopedic digit implants market is consolidated, with prominent companies offering advanced products. Moreover, these players are involved in strategic alliances and focused on geographic expansions to capitalize on the market.

The report includes the profiles of the following key players:

• Extremity Medical LLC (U.S.)
• Stryker (U.S.)
• Smith & Nephew (U.K.)
• DePuy Synthes (Johnson & Johnson) (U.S.)
• Arthrex, Inc. (U.S.)
• Acumed LLC (U.S.)
• VILEX, LLC (U.S.)
• Paragon 28 (Zimmer Biomet) (U.S.)
• CONMED Corporation (U.S.)

Key Industry Developments

• In December 2024, Osteotec Limited re-launched its Osteotec Silicone finger implant in the U.K. and global markets, designed for arthroplasty of the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints.
• In February 2024, AddUp and Anatomic Implants announced the FDA 510(k) Submission for the world’s first 3D printed toe joint replacement.